Centene Total Non-Operating Income/Expense 2012-2026 | CNC
Centene annual/quarterly total non-operating income/expense history and growth rate from 2012 to 2026. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Centene total non-operating income/expense for the quarter ending March 31, 2026 was $238M, a 12.26% increase year-over-year.
- Centene total non-operating income/expense for the twelve months ending March 31, 2026 was $921M, a 0.65% decline year-over-year.
- Centene annual total non-operating income/expense for 2025 was $0.895B, a 17.28% decline from 2024.
- Centene annual total non-operating income/expense for 2024 was $1.082B, a 61.98% increase from 2023.
- Centene annual total non-operating income/expense for 2023 was $0.668B, a 3.73% increase from 2022.
|
Centene Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025 | $895 |
| 2024 | $1,082 |
| 2023 | $668 |
| 2022 | $644 |
| 2021 | $29 |
| 2020 | $-309 |
| 2019 | $1 |
| 2018 | $-90 |
| 2017 | $-65 |
| 2016 | $-103 |
| 2015 | $-8 |
| 2014 | $-7 |
| 2013 | $-8 |
| 2012 | $15 |
| 2011 | $-15 |
|
Centene Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2026-03-31 | $238 |
| 2025-12-31 | $202 |
| 2025-09-30 | $280 |
| 2025-06-30 | $201 |
| 2025-03-31 | $212 |
| 2024-12-31 | $172 |
| 2024-09-30 | $256 |
| 2024-06-30 | $287 |
| 2024-03-31 | $367 |
| 2023-12-31 | $218 |
| 2023-09-30 | $33 |
| 2023-06-30 | $244 |
| 2023-03-31 | $173 |
| 2022-12-31 | $323 |
| 2022-09-30 | $533 |
| 2022-06-30 | $-107 |
| 2022-03-31 | $-105 |
| 2021-12-31 | $91 |
| 2021-09-30 | $175 |
| 2021-06-30 | $-124 |
| 2021-03-31 | $-113 |
| 2020-12-31 | $-89 |
| 2020-09-30 | $-89 |
| 2020-06-30 | $-74 |
| 2020-03-31 | $-57 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $19 |
| 2019-03-31 | |
| 2018-12-31 | $-31 |
| 2018-09-30 | $-17 |
| 2018-06-30 | $-15 |
| 2018-03-31 | $-27 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $-14 |
| 2017-06-30 | $-17 |
| 2017-03-31 | $-21 |
| 2016-12-31 | $-41 |
| 2016-09-30 | $-24 |
| 2016-06-30 | $-20 |
| 2016-03-31 | $-18 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-3 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| 2014-12-31 | |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $18 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $0 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $18.343B | $194.777B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $276.233B | 18.66 |
| Cigna Group (CI) | United States | $71.482B | 9.09 |
| Humana (HUM) | United States | $23.068B | 11.22 |
| Molina Healthcare (MOH) | United States | $7.599B | 13.70 |
| Select Medical Holdings (SEM) | United States | $2.030B | 14.23 |
| Joint (JYNT) | United States | $0.125B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.003B | 0.00 |